APOA2 and ovarian carcinoma: The results showed that the most optimal biomarker combination was a panel of five markers: CA 125, HE4, CA 15-3, APOA1, and APOA2, giving a sensitivity of 93.71% and a specificity of 93.63% for detecting ovarian cancer [86].